Literature DB >> 26629048

MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression.

Xue-Zhi Wu1, Kui-Peng Wang2, Hong-Jie Song3, Jian-Hua Xia4, Yan Jiang5, Yong-Lian Wang6.   

Abstract

Emerging evidence has suggested that dysregulation of microRNA-27a-3p (miR-27a-3p) may contribute to tumor development and progression in various types of cancers. However, its role in esophageal cancer is still unknown. In the present study, miR-27a-3p was significantly increased in esophageal squamous cell carcinoma (ESCC) tissues and cell lines. In esophageal cancer Eca109 cells, ectopic overexpression of miR-27a-3p promoted cell proliferation, meanwhile, cell proliferation was reduced by miR-27a-3p inhibition. Further studies showed that down-regulated miR-27a-3p expression could induced cell cycle arrest at the G1/S transition. In exploring mechanisms underlying the promotive role, our results revealed that miR-27a-3p markedly inhibited the expression of F-box and WD repeat domain-containing 7 (FBXW7). FBXW7, a tumor suppressor, exhibited significantly inhibitory effect on Eca109 cell proliferation. Thus our observations suggested that miR-27a-3p functioned as a tumor suppressor by targeting FBXW7. These findings indicated that miR-27a-3p could be considered as a potential therapeutic strategy for ESCC therapy.

Entities:  

Keywords:  FBXW7; MiR-27a-3p; esophageal cancer; proliferation

Year:  2015        PMID: 26629048      PMCID: PMC4658937     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

Review 1.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.

Authors:  Feng Wang; Jin Xia; Nengchao Wang; Hong Zong
Journal:  Onkologie       Date:  2013-11-20

4.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.

Authors:  Jian-Hua Mao; Jesus Perez-Losada; Di Wu; Reyno Delrosario; Ryosuke Tsunematsu; Keiichi I Nakayama; Ken Brown; Sheila Bryson; Allan Balmain
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

5.  FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.

Authors:  Yu Fu; Youcheng Lin; Zhao Yang; Guosheng Yang; Gaoyuan Li; Yuejia Liu; Xi Tan; Yi Huang; Xun Wu; Yongqiang Wang; Hu Xiong; Meng Zhang; Lu Fang; Yukun Ge; Jun Zeng; Yangke Cai; Jian Bai; Song Wu
Journal:  Med Oncol       Date:  2015-07-11       Impact factor: 3.064

6.  FBXW7/hCDC4 is a general tumor suppressor in human cancer.

Authors:  Shahab Akhoondi; Dahui Sun; Natalie von der Lehr; Sophia Apostolidou; Kathleen Klotz; Alena Maljukova; Diana Cepeda; Heidi Fiegl; Dimitra Dafou; Dimitra Dofou; Christian Marth; Elisabeth Mueller-Holzner; Martin Corcoran; Markus Dagnell; Sepideh Zabihi Nejad; Babak Noori Nayer; Mohammad Reza Zali; Johan Hansson; Susanne Egyhazi; Fredrik Petersson; Per Sangfelt; Hans Nordgren; Dan Grander; Steven I Reed; Martin Widschwendter; Olle Sangfelt; Charles Spruck
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

7.  Treatment outcomes of resected esophageal cancer.

Authors:  Wayne Hofstetter; Stephen G Swisher; Arlene M Correa; Kenneth Hess; Joe B Putnam; Jaffer A Ajani; Marcelo Dolormente; Rhodette Francisco; Ritsuko R Komaki; Axbal Lara; Faye Martin; David C Rice; Arcenio J Sarabia; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

8.  Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.

Authors:  Xing Wang; Juan Zhang; Liang Zhou; Wei Sun; Zhi-Gang Zheng; Peng Lu; Yuan Gao; Xi-Sheng Yang; Zhuo-Chao Zhang; Kai-Shan Tao; Ke-Feng Dou
Journal:  Int J Oncol       Date:  2015-05-04       Impact factor: 5.650

9.  miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma.

Authors:  Lixin Jiang; Yongfang Wang; Yaxiong Rong; Lianhong Xu; Ying Chu; Ying Zhang; Yonghua Yao
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

10.  Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.

Authors:  Wataru Nakata; Motohide Uemura; Mototaka Sato; Kazutoshi Fujita; Kentaro Jingushi; Yuko Ueda; Kaori Kitae; Kazutake Tsujikawa; Norio Nonomura
Journal:  Oncotarget       Date:  2015-08-28
View more
  28 in total

1.  Genome-wide identification and functional analysis of the WDR protein family in potato.

Authors:  Nianjiao Tao; Wenjiao Zhu; Minjie Gan; Min Chen; Ting Li; Alexander Tendu; Dongli Jiao; Man Wang; Chunmei Xue; Yuanmi Lin; Qing Yang
Journal:  3 Biotech       Date:  2019-11-01       Impact factor: 2.406

2.  MiRNA-27a mediates insulin resistance in 3T3-L1 cells through the PPARγ.

Authors:  Yangming Zhuang; Ming Li
Journal:  Mol Cell Biochem       Date:  2022-01-24       Impact factor: 3.396

3.  Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7.

Authors:  Yaomin Chen; Haiyan Wei; Yu Liu; Shusen Zheng
Journal:  Oncol Lett       Date:  2018-01-23       Impact factor: 2.967

4.  Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.

Authors:  Maryna Gorelik; Stephen Orlicky; Maria A Sartori; Xiaojing Tang; Edyta Marcon; Igor Kurinov; Jack F Greenblatt; Mike Tyers; Jason Moffat; Frank Sicheri; Sachdev S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

5.  MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.

Authors:  Lin Zhou; Xin Liang; Lingling Zhang; Liyan Yang; Norio Nagao; Hongkun Wu; Chang Liu; Shengchao Lin; Guoxiang Cai; Jianwen Liu
Journal:  Oncotarget       Date:  2016-08-09

6.  A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.

Authors:  Giovanna Marziali; Mariachiara Buccarelli; Alessandro Giuliani; Ramona Ilari; Sveva Grande; Alessandra Palma; Quintino G D'Alessandris; Maurizio Martini; Mauro Biffoni; Roberto Pallini; Lucia Ricci-Vitiani
Journal:  Mol Oncol       Date:  2017-07-13       Impact factor: 6.603

7.  Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10.

Authors:  Lihua Li; Zhaohui Luo
Journal:  Oncol Rep       Date:  2017-03-31       Impact factor: 3.906

8.  Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.

Authors:  Chiara Gai; Francesco Camussi; Roberto Broccoletti; Alessio Gambino; Marco Cabras; Luca Molinaro; Stefano Carossa; Giovanni Camussi; Paolo G Arduino
Journal:  BMC Cancer       Date:  2018-04-18       Impact factor: 4.430

9.  miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.

Authors:  Jiangtao Liang; Jianming Tang; Huijuan Shi; Hui Li; Tiantian Zhen; Jing Duan; Lili Kang; Fenfen Zhang; Yu Dong; Anjia Han
Journal:  Oncotarget       Date:  2017-07-26

10.  SCF FBXW17 E3 ubiquitin ligase regulates FBXL19 stability and cell migration.

Authors:  Su Dong; Jianxin Wei; Rachel K Bowser; Bill B Chen; Rama K Mallampalli; Jiaxing Miao; Qinmao Ye; Kevin C Tran; Yutong Zhao; Jing Zhao
Journal:  J Cell Biochem       Date:  2020-10-14       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.